Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis

Justin G. Madson, David T. Lynch, Jessica Svoboda, Rebecca Ophardt, Jodi Yanagida, Sumanth K. Putta, Andrew Bowles, Carol S. Trempus, Raymond W. Tennant, Laura A. Hansen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The Erbb2 receptor is activated by UV irradiation, the primary cause of non-melanoma skin cancer. We hypothesized that Erbb2 activation contributes to UV-induced skin tumorigenesis by suppressing cell cycle arrest. Consistent with this hypothesis, inhibition of Erbb2 in v-rasHa transgenic mice before UV exposure resulted in both 56% fewer skin tumors and tumors that were 70% smaller. Inhibition of the UV-induced activation of Erbb2 also resulted in milder epidermal hyperplasia, S-phase accumulation, and decreased levels of the cell cycle regulator Cdc25a, suggesting altered cell cycle regulation on inhibition of Erbb2. Further investigation using inhibition or genetic deletion of Erbb2 in vitro revealed reduced Cdc25a levels and increased S-phase arrest in UV-irradiated cells lacking Erbb2 activity. Ectopic expression of Cdc25a prevented UV-induced S-phase arrest in keratinocytes lacking Erbb2 activity, demonstrating that maintenance of Cdc25a by Erbb2 suppresses cell cycle arrest. Examination of checkpoint pathway activation upstream of Cdc25a revealed Erbb2 activation did not alter Ataxia Telangiectasia and Rad3-related/Ataxia Telangiectasia Mutated activity but increased inhibitory phosphorylation of Chk1-Ser280. Since Akt phosphorylates Chk1-Ser280, the effect of Erbb2 on phosphatidyl inositol-3-kinase (PI3K)/Akt signaling during UV-induced cell cycle arrest was determined. Erbb2 ablation reduced the UV-induced activation of PI3K while inhibition of PI3K/Akt increased UV-induced S-phase arrest. Thus, UV-induced Erbb2 activation increases skin tumorigenesis through inhibitory phosphorylation of Chk1, Cdc25a maintenance, and suppression of S-phase arrest via a PI3K/Akt-dependent mechanism.

Original languageEnglish
Pages (from-to)2357-2366
Number of pages10
JournalAmerican Journal of Pathology
Volume174
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

S Phase
DNA Damage
Phosphatidylinositols
Carcinogenesis
Phosphotransferases
Skin
Cell Cycle Checkpoints
Ataxia Telangiectasia
Cell Cycle
Maintenance
Phosphorylation
Skin Neoplasms
Keratinocytes
Transgenic Mice
Hyperplasia
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis. / Madson, Justin G.; Lynch, David T.; Svoboda, Jessica; Ophardt, Rebecca; Yanagida, Jodi; Putta, Sumanth K.; Bowles, Andrew; Trempus, Carol S.; Tennant, Raymond W.; Hansen, Laura A.

In: American Journal of Pathology, Vol. 174, No. 6, 06.2009, p. 2357-2366.

Research output: Contribution to journalArticle

Madson, JG, Lynch, DT, Svoboda, J, Ophardt, R, Yanagida, J, Putta, SK, Bowles, A, Trempus, CS, Tennant, RW & Hansen, LA 2009, 'Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis', American Journal of Pathology, vol. 174, no. 6, pp. 2357-2366. https://doi.org/10.2353/ajpath.2009.080638
Madson, Justin G. ; Lynch, David T. ; Svoboda, Jessica ; Ophardt, Rebecca ; Yanagida, Jodi ; Putta, Sumanth K. ; Bowles, Andrew ; Trempus, Carol S. ; Tennant, Raymond W. ; Hansen, Laura A. / Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis. In: American Journal of Pathology. 2009 ; Vol. 174, No. 6. pp. 2357-2366.
@article{fbeca23810a44fcea9eb7518b416be10,
title = "Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis",
abstract = "The Erbb2 receptor is activated by UV irradiation, the primary cause of non-melanoma skin cancer. We hypothesized that Erbb2 activation contributes to UV-induced skin tumorigenesis by suppressing cell cycle arrest. Consistent with this hypothesis, inhibition of Erbb2 in v-rasHa transgenic mice before UV exposure resulted in both 56{\%} fewer skin tumors and tumors that were 70{\%} smaller. Inhibition of the UV-induced activation of Erbb2 also resulted in milder epidermal hyperplasia, S-phase accumulation, and decreased levels of the cell cycle regulator Cdc25a, suggesting altered cell cycle regulation on inhibition of Erbb2. Further investigation using inhibition or genetic deletion of Erbb2 in vitro revealed reduced Cdc25a levels and increased S-phase arrest in UV-irradiated cells lacking Erbb2 activity. Ectopic expression of Cdc25a prevented UV-induced S-phase arrest in keratinocytes lacking Erbb2 activity, demonstrating that maintenance of Cdc25a by Erbb2 suppresses cell cycle arrest. Examination of checkpoint pathway activation upstream of Cdc25a revealed Erbb2 activation did not alter Ataxia Telangiectasia and Rad3-related/Ataxia Telangiectasia Mutated activity but increased inhibitory phosphorylation of Chk1-Ser280. Since Akt phosphorylates Chk1-Ser280, the effect of Erbb2 on phosphatidyl inositol-3-kinase (PI3K)/Akt signaling during UV-induced cell cycle arrest was determined. Erbb2 ablation reduced the UV-induced activation of PI3K while inhibition of PI3K/Akt increased UV-induced S-phase arrest. Thus, UV-induced Erbb2 activation increases skin tumorigenesis through inhibitory phosphorylation of Chk1, Cdc25a maintenance, and suppression of S-phase arrest via a PI3K/Akt-dependent mechanism.",
author = "Madson, {Justin G.} and Lynch, {David T.} and Jessica Svoboda and Rebecca Ophardt and Jodi Yanagida and Putta, {Sumanth K.} and Andrew Bowles and Trempus, {Carol S.} and Tennant, {Raymond W.} and Hansen, {Laura A.}",
year = "2009",
month = "6",
doi = "10.2353/ajpath.2009.080638",
language = "English",
volume = "174",
pages = "2357--2366",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis

AU - Madson, Justin G.

AU - Lynch, David T.

AU - Svoboda, Jessica

AU - Ophardt, Rebecca

AU - Yanagida, Jodi

AU - Putta, Sumanth K.

AU - Bowles, Andrew

AU - Trempus, Carol S.

AU - Tennant, Raymond W.

AU - Hansen, Laura A.

PY - 2009/6

Y1 - 2009/6

N2 - The Erbb2 receptor is activated by UV irradiation, the primary cause of non-melanoma skin cancer. We hypothesized that Erbb2 activation contributes to UV-induced skin tumorigenesis by suppressing cell cycle arrest. Consistent with this hypothesis, inhibition of Erbb2 in v-rasHa transgenic mice before UV exposure resulted in both 56% fewer skin tumors and tumors that were 70% smaller. Inhibition of the UV-induced activation of Erbb2 also resulted in milder epidermal hyperplasia, S-phase accumulation, and decreased levels of the cell cycle regulator Cdc25a, suggesting altered cell cycle regulation on inhibition of Erbb2. Further investigation using inhibition or genetic deletion of Erbb2 in vitro revealed reduced Cdc25a levels and increased S-phase arrest in UV-irradiated cells lacking Erbb2 activity. Ectopic expression of Cdc25a prevented UV-induced S-phase arrest in keratinocytes lacking Erbb2 activity, demonstrating that maintenance of Cdc25a by Erbb2 suppresses cell cycle arrest. Examination of checkpoint pathway activation upstream of Cdc25a revealed Erbb2 activation did not alter Ataxia Telangiectasia and Rad3-related/Ataxia Telangiectasia Mutated activity but increased inhibitory phosphorylation of Chk1-Ser280. Since Akt phosphorylates Chk1-Ser280, the effect of Erbb2 on phosphatidyl inositol-3-kinase (PI3K)/Akt signaling during UV-induced cell cycle arrest was determined. Erbb2 ablation reduced the UV-induced activation of PI3K while inhibition of PI3K/Akt increased UV-induced S-phase arrest. Thus, UV-induced Erbb2 activation increases skin tumorigenesis through inhibitory phosphorylation of Chk1, Cdc25a maintenance, and suppression of S-phase arrest via a PI3K/Akt-dependent mechanism.

AB - The Erbb2 receptor is activated by UV irradiation, the primary cause of non-melanoma skin cancer. We hypothesized that Erbb2 activation contributes to UV-induced skin tumorigenesis by suppressing cell cycle arrest. Consistent with this hypothesis, inhibition of Erbb2 in v-rasHa transgenic mice before UV exposure resulted in both 56% fewer skin tumors and tumors that were 70% smaller. Inhibition of the UV-induced activation of Erbb2 also resulted in milder epidermal hyperplasia, S-phase accumulation, and decreased levels of the cell cycle regulator Cdc25a, suggesting altered cell cycle regulation on inhibition of Erbb2. Further investigation using inhibition or genetic deletion of Erbb2 in vitro revealed reduced Cdc25a levels and increased S-phase arrest in UV-irradiated cells lacking Erbb2 activity. Ectopic expression of Cdc25a prevented UV-induced S-phase arrest in keratinocytes lacking Erbb2 activity, demonstrating that maintenance of Cdc25a by Erbb2 suppresses cell cycle arrest. Examination of checkpoint pathway activation upstream of Cdc25a revealed Erbb2 activation did not alter Ataxia Telangiectasia and Rad3-related/Ataxia Telangiectasia Mutated activity but increased inhibitory phosphorylation of Chk1-Ser280. Since Akt phosphorylates Chk1-Ser280, the effect of Erbb2 on phosphatidyl inositol-3-kinase (PI3K)/Akt signaling during UV-induced cell cycle arrest was determined. Erbb2 ablation reduced the UV-induced activation of PI3K while inhibition of PI3K/Akt increased UV-induced S-phase arrest. Thus, UV-induced Erbb2 activation increases skin tumorigenesis through inhibitory phosphorylation of Chk1, Cdc25a maintenance, and suppression of S-phase arrest via a PI3K/Akt-dependent mechanism.

UR - http://www.scopus.com/inward/record.url?scp=67049162195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049162195&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2009.080638

DO - 10.2353/ajpath.2009.080638

M3 - Article

VL - 174

SP - 2357

EP - 2366

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 6

ER -